| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abdominal radiation and diabetes: one more piece in the puzzle
|
Oeffinger, Kevin C
|
|
2012
|
13 |
10 |
p. 961-962
2 p.
|
artikel
|
| 2 |
Abiraterone acetate for metastatic prostate cancer
|
Sonpavde, Guru
|
|
2012
|
13 |
10 |
p. 958-959
2 p.
|
artikel
|
| 3 |
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
|
Fizazi, Karim
|
|
2012
|
13 |
10 |
p. 983-992
10 p.
|
artikel
|
| 4 |
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
|
Camidge, D Ross
|
|
2012
|
13 |
10 |
p. 1011-1019
9 p.
|
artikel
|
| 5 |
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
|
Woll, Penella J
|
|
2012
|
13 |
10 |
p. 1045-1054
10 p.
|
artikel
|
| 6 |
Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study
|
Santini, Daniele
|
|
2012
|
13 |
10 |
p. 1020-1024
5 p.
|
artikel
|
| 7 |
Aprepitant for pruritus: drug–drug interactions matter
|
Mir, Olivier
|
|
2012
|
13 |
10 |
p. 964-965
2 p.
|
artikel
|
| 8 |
Balancing priorities in China's expanding health-care system
|
Alcorn, Ted
|
|
2012
|
13 |
10 |
p. 975-
1 p.
|
artikel
|
| 9 |
Cancer is SO FUNNY!
|
Yaqub, Farhat
|
|
2012
|
13 |
10 |
p. 980-981
2 p.
|
artikel
|
| 10 |
Choosing the right option for renal-cell carcinoma
|
Bex, Axel
|
|
2012
|
13 |
10 |
p. 970-971
2 p.
|
artikel
|
| 11 |
Clinical trials: round-up
|
Astudillo, Olaya
|
|
2012
|
13 |
10 |
p. 976-
1 p.
|
artikel
|
| 12 |
Correction to Lancet Oncol 2012; 13: 1045
|
|
|
2012
|
13 |
10 |
p. e412-
1 p.
|
artikel
|
| 13 |
Crizotinib in ALK-positive lung cancer
|
Girard, Nicolas
|
|
2012
|
13 |
10 |
p. 962-963
2 p.
|
artikel
|
| 14 |
Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits
|
Brasme, Jean-François
|
|
2012
|
13 |
10 |
p. e445-e459
nvt p.
|
artikel
|
| 15 |
Dickkopf-1 and hepatocellular carcinoma
|
Tsai, Jung-Fa
|
|
2012
|
13 |
10 |
p. e410-
1 p.
|
artikel
|
| 16 |
Dickkopf-1 and hepatocellular carcinoma – Authors' reply
|
Shen, Qiujin
|
|
2012
|
13 |
10 |
p. e410-e411
nvt p.
|
artikel
|
| 17 |
EGFR mutations in circulating tumour DNA
|
Rosell, Rafael
|
|
2012
|
13 |
10 |
p. 971-973
3 p.
|
artikel
|
| 18 |
Enzalutamide for prostate cancer
|
Tanday, Sanjay
|
|
2012
|
13 |
10 |
p. e413-
1 p.
|
artikel
|
| 19 |
Expanded Medicaid coverage in the USA reduces mortality
|
Bennet, Neil
|
|
2012
|
13 |
10 |
p. e417-
1 p.
|
artikel
|
| 20 |
Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review
|
Hamaker, Marije E
|
|
2012
|
13 |
10 |
p. e437-e444
nvt p.
|
artikel
|
| 21 |
Friendly fire in the war on cancer
|
Peppercorn, Jeffrey
|
|
2012
|
13 |
10 |
p. 982-
1 p.
|
artikel
|
| 22 |
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study
|
Smits, Maarten LJ
|
|
2012
|
13 |
10 |
p. 1025-1034
10 p.
|
artikel
|
| 23 |
Hope for personalised treatment of squamous-cell lung cancer
|
Benmaamar, Ramla
|
|
2012
|
13 |
10 |
p. e416-
1 p.
|
artikel
|
| 24 |
Intensity of conditioning for allogeneic haemopoetic cell transplantation
|
Estey, Elihu H
|
|
2012
|
13 |
10 |
p. 966-968
3 p.
|
artikel
|
| 25 |
Is adjuvant chemotherapy useful for soft-tissue sarcomas?
|
D'adamo, David
|
|
2012
|
13 |
10 |
p. 968-970
3 p.
|
artikel
|
| 26 |
Minimising central-line infections in vulnerable children
|
Wilkinson, Emma
|
|
2012
|
13 |
10 |
p. e415-
1 p.
|
artikel
|
| 27 |
New evidence for a genetic cause of Barrett's oesophagus
|
Marshall, Hilary
|
|
2012
|
13 |
10 |
p. e416-
1 p.
|
artikel
|
| 28 |
NICE guidance on bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
|
Umeweni, Nwamaka
|
|
2012
|
13 |
10 |
p. 977-978
2 p.
|
artikel
|
| 29 |
Now is good
|
Whinder, Frances
|
|
2012
|
13 |
10 |
p. 979-
1 p.
|
artikel
|
| 30 |
Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment
|
Schneider, Bryan P
|
|
2012
|
13 |
10 |
p. e427-e436
nvt p.
|
artikel
|
| 31 |
Plain cigarette packaging: Australia's victory
|
Kirby, Tony
|
|
2012
|
13 |
10 |
p. e414-
1 p.
|
artikel
|
| 32 |
PTEN link between cancer and diabetes
|
Heald, Rebecca
|
|
2012
|
13 |
10 |
p. e417-
1 p.
|
artikel
|
| 33 |
Quality-of-life effects of screening for prostate cancer
|
Wilkinson, Emma
|
|
2012
|
13 |
10 |
p. e414-
1 p.
|
artikel
|
| 34 |
Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study
|
de Vathaire, Florent
|
|
2012
|
13 |
10 |
p. 1002-1010
9 p.
|
artikel
|
| 35 |
Radiation exposure following Fukushima incident
|
Wu, Dawei
|
|
2012
|
13 |
10 |
p. e413-
1 p.
|
artikel
|
| 36 |
Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial
|
Bornhäuser, Martin
|
|
2012
|
13 |
10 |
p. 1035-1044
10 p.
|
artikel
|
| 37 |
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial
|
Eisen, Tim
|
|
2012
|
13 |
10 |
p. 1055-1062
8 p.
|
artikel
|
| 38 |
Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy
|
Drilon, Alexander
|
|
2012
|
13 |
10 |
p. e418-e426
nvt p.
|
artikel
|
| 39 |
9/11 survivors to get free cancer treatment
|
The Lancet Oncology,
|
|
2012
|
13 |
10 |
p. 957-
1 p.
|
artikel
|
| 40 |
TAS-102 in refractory colorectal cancer: caution is needed
|
Sobrero, Alberto
|
|
2012
|
13 |
10 |
p. 959-961
3 p.
|
artikel
|
| 41 |
TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial
|
Yoshino, Takayuki
|
|
2012
|
13 |
10 |
p. 993-1001
9 p.
|
artikel
|
| 42 |
The evolution of radioembolisation
|
Cosimelli, Maurizio
|
|
2012
|
13 |
10 |
p. 965-966
2 p.
|
artikel
|
| 43 |
The link between lung cancer and indoor air pollution
|
Burki, Talha Khan
|
|
2012
|
13 |
10 |
p. e415-
1 p.
|
artikel
|
| 44 |
Trametinib for patients with advanced melanoma
|
Masuda, Shigeo
|
|
2012
|
13 |
10 |
p. e409-
1 p.
|
artikel
|
| 45 |
Trametinib for patients with advanced melanoma – Authors' reply
|
Falchook, Gerald S
|
|
2012
|
13 |
10 |
p. e409-e410
nvt p.
|
artikel
|
| 46 |
Unprovoked venous thromboembolism: assess for cancer
|
Shaboodien, Roekshana
|
|
2012
|
13 |
10 |
p. 973-974
2 p.
|
artikel
|
| 47 |
Until Further Notice, I Am Alive
|
O'Donoghue, Odhran
|
|
2012
|
13 |
10 |
p. 980-
1 p.
|
artikel
|
| 48 |
Voices from the front: October
|
Mastrianni, David M
|
|
2012
|
13 |
10 |
p. 982-
1 p.
|
artikel
|
| 49 |
When I Die: Lessons from the Death Zone
|
Burki, Talha Khan
|
|
2012
|
13 |
10 |
p. 981-982
2 p.
|
artikel
|
Tijdschrift beschrijving